Autolus Therapeutics (AUTL) Payables (2017 - 2025)
Historic Payables for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $11.0 million.
- Autolus Therapeutics' Payables rose 67341.33% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 67341.33%. This contributed to the annual value of $2.0 million for FY2024, which is 181165.05% up from last year.
- As of Q3 2025, Autolus Therapeutics' Payables stood at $11.0 million, which was up 67341.33% from $5.4 million recorded in Q2 2025.
- Autolus Therapeutics' Payables' 5-year high stood at $11.0 million during Q3 2025, with a 5-year trough of -$1.3 million in Q2 2021.
- Moreover, its 5-year median value for Payables was $531000.0 (2022), whereas its average is $1.7 million.
- As far as peak fluctuations go, Autolus Therapeutics' Payables crashed by 30543.13% in 2021, and later skyrocketed by 195507.25% in 2024.
- Quarter analysis of 5 years shows Autolus Therapeutics' Payables stood at $431000.0 in 2021, then increased by 23.2% to $531000.0 in 2022, then plummeted by 80.6% to $103000.0 in 2023, then surged by 1811.65% to $2.0 million in 2024, then skyrocketed by 456.98% to $11.0 million in 2025.
- Its last three reported values are $11.0 million in Q3 2025, $5.4 million for Q2 2025, and $4.5 million during Q1 2025.